Octapharma, one of the largest independent manufacturers of human protein products worldwide, has added the PAS-X Track & Trace Serialization Aggregation solution to Werum–s PAS-X at their production site in Vienna.
LOS ANGELES, CA — (Marketwired) — 09/17/14 — (OTCQB: MMRF) ("MMR" or the "Company") today announced that it has received another significant milestone payment pursuant to an existing Non-Exclusive License Agreement (the "Agreement") pertaining to the Company–s biotech assets. Additional information regarding this milestone payment will be contained in the Company–s quarterly report on Form 10-Q for the quarter ending September 30, 2014. The non-exclusive Agre
The Japanese biotech company UNIGEN Inc. has taken Werum-s PAS-X Manufacturing Execution System (MES) into operation within a record time of only four months. The short implementation time was possible because the company relied on a standard solution. PAS-X is operational with all functionalities out of the box. UNIGEN implemented PAS-X using Werum’s four-phased fast-track implementation methodology: Ready, Fit, Build and Run. Part of the project and a big success element was the flexible and e
In cooperation with the PAS-X User Community, Werum further improved the leading Manufacturing Execution System (MES) for pharmaceutical and biotechnological production. "We integrated new features and improved the usability, making working with PAS-X even easier and more efficient", says Robert Welter, Head of PAS-X Product Management, Werum IT Solutions GmbH. "PAS-X is a functionally complete and scalable MES out of the box, which widely automates actions that previously had to
The pharmaceutical major Dr. Reddy’s Laboratories Ltd. successfully rolled out Werum’s PAS-X Manufacturing IT Business Platform at their Indian greenfield site in Visakhapatnam. Dr. Reddy’s deployed PAS-X for the first time as full-blown MES covering all operations from material receipt to production.
LOS ANGELES, CA — (Marketwired) — 10/02/13 — (OTCQB: MMRF) ("MMR"), a leading provider of (PHRs), storage solutions and electronic document management and imaging systems for , today announced that two additional patents will be granted for its B-cell vaccine technologies. MMR has been notified it will receive another U.S. patent protecting methods of making compositions for B-cell vaccines pursuant to a Notice of Allowance from the United States Patent and Trademark Office. The
Demonstration of PyMOL and Avogadro Software at zSpace Booth #1731
BioTech Startup Boom on Long Island With 25 BioTech Startups
Subscriber Data Integration for Enterprise Subscriptions
LOS ANGELES, CA — (Marketwired) — 05/28/13 — (OTCQB: MMRF) ("MMR" or the "Company") today announced that Ivor Royston, M.D. has agreed to join the Company-s Board of Directors effective immediately. MMR-s Board of Directors voted unanimously to authorize management of the Company to extend an invitation to Dr. Royston to serve on the Board. MMR-s management and the Board believe it is in the best interest of the Company and its stockholders to have a director whose exper